IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4913 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed7618    
    Printed129    
    Emailed4    
    PDF Downloaded594    
    Comments [Add]    
    Cited by others 17    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2007  |  Volume : 73  |  Issue : 4  |  Page : 231--234

Effect of oral granisetron in uremic pruritus


1 Department of Dermatology, Qaem Hospital, Mashad University of Medical Sciences, Mashad, Iran
2 Department of Renal Medicine, Qaem Hospital, Mashad University of Medical Sciences, Mashad, Iran
3 Mashad University of Medical Sciences, Mashad, Iran
4 Department of Renal Medicine, Imam Reza Hospital, Mashad University of Medical Sciences, Mashad, Iran

Correspondence Address:
Pouran Layegh
Department of Dermatology, Qaem Hospital, Mashad University of Medical Sciences, Mashad
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.32887

Rights and Permissions

Background : Renal itch is a relatively common and distressing problem for patients with chronic renal failure. Granisetron, is a potent and selective inhibitor of 5-HT3 receptors. There have been some studies about the effect of ondansetron in uremic pruritus and one case report has recently described relief of renal itch with granisetron. Aims : To evaluate the effect of Granisetron on uremic pruritus in Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis (HD) patients. Methods: To study the prevalence of uremic pruritus, patients on CAPD and HD were asked to complete a pruritus questionnaire.Their replies were scored based on numerical scales. Pruritus was graded, according to the total points for each patient, as mild, moderate or severe. Fourteen patients with moderate to severe pruritus were enrolled in the trial. During treatment, patients received granisetron (1 mg tablet twice a day P.O), for a period of 1 month. They were asked to score the severity of pruritus twice a day. Results : Seventy seven percent of the patients responded to the treatment and at 1 st , 2 nd and 4 th week the mean values of the pruritus scores were 23, 16 and 8 points respectively. Before starting treatment the score was 31 points ( P =0.03). Weekly clinical and laboratory examination showed no important side effects. Conclusion : Granisetron might be an effective, safe and well tolerated drug for the treatment of uremic pruritus.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow